Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 19


Glutamatergic agents for OCD and related disorders.

Pittenger C.

Curr Treat Options Psychiatry. 2015 Sep;2(3):271-283.


Topiramate augmentation in a patient with obsessive-compulsive disorder.

Van Ameringen M, Patterson B.

J Psychiatry Neurosci. 2015 Sep;40(5):E31-2. No abstract available.


Glutamate modulators in the treatment of obsessive-compulsive disorder.

Pittenger C.

Psychiatr Ann. 2015 Jun;45(6):308-315.


Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial.

Pittenger C, Bloch MH, Wasylink S, Billingslea E, Simpson R, Jakubovski E, Kelmendi B, Sanacora G, Coric V.

J Clin Psychiatry. 2015 Aug;76(8):1075-84. doi: 10.4088/JCP.14m09123.


Assessment and management of treatment-refractory obsessive-compulsive disorder in children.

Bloch MH, Storch EA.

J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):251-62. doi: 10.1016/j.jaac.2015.01.011. Epub 2015 Jan 30. Review.


Pharmacological treatment of obsessive-compulsive disorder.

Pittenger C, Bloch MH.

Psychiatr Clin North Am. 2014 Sep;37(3):375-91. doi: 10.1016/j.psc.2014.05.006. Epub 2014 Jul 24. Review.


Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M; Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University, Antony MM, Bouchard S, Brunet A, Flament M, Grigoriadis S, Mendlowitz S, O'Connor K, Rabheru K, Richter PM, Robichaud M, Walker JR.

BMC Psychiatry. 2014;14 Suppl 1:S1. doi: 10.1186/1471-244X-14-S1-S1. Epub 2014 Jul 2. Review.


Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder.

Anticevic A, Hu S, Zhang S, Savic A, Billingslea E, Wasylink S, Repovs G, Cole MW, Bednarski S, Krystal JH, Bloch MH, Li CS, Pittenger C.

Biol Psychiatry. 2014 Apr 15;75(8):595-605. doi: 10.1016/j.biopsych.2013.10.021. Epub 2013 Nov 4.


The Genetics of Obsessive-Compulsive Disorder.

Bloch MH, Pittenger C.

Curr Psychiatry Rev. 2010 May 1;6(2):91-103.


From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.

Sanacora G, Banasr M.

Biol Psychiatry. 2013 Jun 15;73(12):1172-9. doi: 10.1016/j.biopsych.2013.03.032. Review.


Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder.

Porton B, Greenberg BD, Askland K, Serra LM, Gesmonde J, Rudnick G, Rasmussen SA, Kao HT.

Transl Psychiatry. 2013 May 21;3:e259. doi: 10.1038/tp.2013.35.


Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Pittenger C, Bloch MH, Williams K.

Pharmacol Ther. 2011 Dec;132(3):314-32. doi: 10.1016/j.pharmthera.2011.09.006. Epub 2011 Sep 22. Review.


Psychotherapy and medication management strategies for obsessive-compulsive disorder.

Walsh KH, McDougle CJ.

Neuropsychiatr Dis Treat. 2011;7:485-94. doi: 10.2147/NDT.S13205. Epub 2011 Aug 23.


Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder.

Grant P, Song JY, Swedo SE.

J Child Adolesc Psychopharmacol. 2010 Aug;20(4):309-15. doi: 10.1089/cap.2010.0009. Review.


Current trends in drug treatment of obsessive-compulsive disorder.

Decloedt EH, Stein DJ.

Neuropsychiatr Dis Treat. 2010 May 25;6:233-42.


Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics.

Jacob S, Landeros-Weisenberger A, Leckman JF.

Autism Res. 2009 Dec;2(6):293-311. doi: 10.1002/aur.108. Review.


Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Ting JT, Feng G.

Curr Chem Genomics. 2008 Jan 1;2:62-75.


Obsessive-compulsive disorder and related disorders: a comprehensive survey.

Fornaro M, Gabrielli F, Albano C, Fornaro S, Rizzato S, Mattei C, Solano P, Vinciguerra V, Fornaro P.

Ann Gen Psychiatry. 2009 May 18;8:13. doi: 10.1186/1744-859X-8-13.


Symptom dimensions and subtypes of obsessive-compulsive disorder: a developmental perspective.

Leckman JF, Bloch MH, King RA.

Dialogues Clin Neurosci. 2009;11(1):21-33. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk